No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CDTX Cidara Therapeutics
- 12.6300
- -0.3700-2.85%
Close Apr 26 16:00 ET
- 12.5300
- -0.1000-0.79%
Post 19:58 ET
57.61MMarket Cap-2428P/E (TTM)
13.4300High11.5700Low200.11KVolume12.6500Open13.0000Pre Close2.56MTurnover5.16%Turnover RatioLossP/E (Static)4.56MShares29.600052wk High-7.02P/B49.00MFloat Cap10.000052wk Low--Dividend TTM3.88MShs Float382.6000Historical High--Div YieldTTM14.31%Amplitude8.0000Historical Low12.7880Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024
The first presentation highlights data from the Phase 2a study of CD388, showing the DFC was well tolerated and demonstrated statistically significant antiviral effects when administered as a single subcutaneous dose in healthy volunteers challenged with influenza.
Cidara Therapeutics Is Maintained at Buy by Needham
Cidara Therapeutics Is Maintained at Buy by Needham
Express News | Needham Maintains Buy on Cidara Therapeutics, Adjusts Price Target To $25
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first
Express News | Cantor Fitzgerald Reiterates Overweight on Cidara Therapeutics
Cidara Therapeutics Stock Jumps 13% As It Reacquires Rights To Influenza Drug
Comments
$Cidara Therapeutics(CDTX.US$
NEWS
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024
Cidara Therapeutics announced data presentations at ESCMID 2024 on CD388, highlighting Phase 1 and Phase 2a clinical data. The Phase 2a study showed CD388 was well-tolerated with significant antiviral effects in healthy volunteers challenged with influenza. The Phase 1 study demonstrated an extended half-life of 6-8 weeks, indicating potential f...
NEWS
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024
Cidara Therapeutics announced data presentations at ESCMID 2024 on CD388, highlighting Phase 1 and Phase 2a clinical data. The Phase 2a study showed CD388 was well-tolerated with significant antiviral effects in healthy volunteers challenged with influenza. The Phase 1 study demonstrated an extended half-life of 6-8 weeks, indicating potential f...
1
$CDTX Support / Resistance Levels
CDTX continues to move up in overnight trading. Here are the levels to keep on watch tomorrow.
Larger Image: tradingview.com...
$Cidara Therapeutics(CDTX.US$
Larger Image: tradingview.com...
$Cidara Therapeutics(CDTX.US$
$Cidara Therapeutics(CDTX.US$
Hopefully it'll continue to run tomorrow?
Hopefully it'll continue to run tomorrow?
Here is the full lowdown! Hehehe. Or as some say. Here’s the rest of the story! Hehehe
$Cidara Therapeutics(CDTX.US$ Cidara Therapeutics To Sell Candidiasis Treatment, Re-acquire Flu Asset
WSJ· 4 mins ago
Cidara Therapeutics said it would sell its candidiasis treatment rezafungin to its partner and buy back the license to its potential influenza-prevention treatment.
The San Diego-based biotechnology company said Wednesday that it was divesting the treatment, sold under the brand name Rezzayo, t...
WSJ· 4 mins ago
Cidara Therapeutics said it would sell its candidiasis treatment rezafungin to its partner and buy back the license to its potential influenza-prevention treatment.
The San Diego-based biotechnology company said Wednesday that it was divesting the treatment, sold under the brand name Rezzayo, t...
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg